NASDAQ: OPTHOptimi Health Corp Stock
$5.70-0.38 (-6.25%)
Updated May 21, 2026
OPTH Price
$5.70
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$4.96
52 Week High
$6.40
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.84
Operating Cash Flow
N/A
Beta
N/A
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OPTH Overview
Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. It offers formulation, active pharmaceutical ingredients (APIs), and drug product manufacturing from preclinical stages to analysis and commercial distribution and It also offers botanical psilocybin and MDMA. The company was founded on May 27, 2020 and is headquartered in Squamish, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OPTH's potential to beat the market
- OPTH doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important OPTH news, forecast changes, insider trades & much more!
OPTH News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OPTH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OPTH's short-term liabilities ($6.67M) exceed its short-term assets ($816.99k)
Short-term Liabilities Financials
OPTH's short-term assets ($816.99k) exceed its long-term liabilities ($110.98k)
Long-term Liabilities Financials
OPTH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
There are 30 more OPTH due diligence checks available for Premium users.
Valuation
OPTH's financial health
Profit margin
Revenue
$0.0
Net Income
-$1.1M
Profit Margin
0%
Assets to liabilities
Assets
$10.4M
Liabilities
$6.7M
Debt to equity
1.84
OPTH's short-term liabilities ($6.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OPTH's short-term assets ($816.99k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OPTH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$465.0k
Investing
-$2.5k
Financing
-$9.4k
Optimi Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.